Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
LUPIN LTD.
Lupin Ltd.
NSE: LUPIN | BSE: 500257
Mid-range Performer
Download real time
1995.00
40.20
(
2.06
%)
528.2K
NSE+BSE Volume
NSE
04 Jul, 2025 12:30 PM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
US FDA Approval
Lupin receives US FDA approval for its ANDA for Loteprednol Etabonate Ophthalmic Gel
See details
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
GET EVENTS ALERTS
LIVE SAMPLE
Daily Digest
Split history for Lupin Ltd.
Lupin Ltd. has split the face value 1 time since Aug. 27, 2010. Lupin Ltd. had last split the face value of its shares from ₹10 to ₹2 in 2010.The share has been quoting on an ex-split basis from Aug. 27, 2010.
Ex-Date
Old FV
New FV
Record Date
27 Aug 2010
10
2
30 Aug 2010
See all forthcoming Bonus and split